New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For HITK;AEZS;AMED;IMGN;HTWR;CRVL;SQNM;MDAS;DSCI;CCRN From The Last 14 Days
Check below for free stories on HITK;AEZS;AMED;IMGN;HTWR;CRVL;SQNM;MDAS;DSCI;CCRN the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 19, 2014
11:32 EDTSQNMLabCorp prenatal test a negative for Sequenom, says Maxim
Maxim views LabCorp's (LH) announcement today that it will begin offering the informaSeq prenatal test as a long-term negative for Sequenom (SQNM) due to increased competition. The news is also negative for Illumina (ILMN) and PerkinElmer (PKI), who both offer Non-Invasive Prenatal Tests, Maxim adds. The firm recommends buying shares of LabCorp and keeps a Buy rating on the name with a $130 price target.
10:13 EDTMDASOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:09 EDTMDASMedAssets upgraded to Outperform from Market Perform at Leerink
Leerink upgraded MedAssets to Outperform citing the pullback in shares since the Q2 results, the potential for improving volumes in Q3 and the company's total portfolio approach. The firm has a $26 price target for shares.
06:04 EDTMDASMedAssets upgraded to Outperform from Market Perform at Leerink
Subscribe for More Information
August 14, 2014
07:39 EDTMDASMedAssets pullback a buying opportunity, says Jefferies
Jefferies believes MedAssets' core business is back on track following yesterday's analyst day and it recommends buying the stock on the recent pullback. The firm has a Buy rating on the name with a $30 price target.
August 13, 2014
08:02 EDTMDASMedAssets acquires SG-2 for approximately $142M
Subscribe for More Information
August 12, 2014
15:53 EDTDSCICanaccord to hold a conference
34th Annual Growth Conference to be held in Boston on August 13-14.
August 11, 2014
06:57 EDTAMED, MDASAvondale to hold a conference
Subscribe for More Information
August 7, 2014
17:14 EDTAEZSAeterna Zentaris reports Q2 EPS (9c), consensus (19c)
Subscribe for More Information
15:01 EDTAMEDAmedisys management to meet with SunTrust
Subscribe for More Information
14:51 EDTHTWRThoratec investors should not move to sidelines, says Barrington
Subscribe for More Information
07:37 EDTDSCIDerma Sciences sees FY14 net sales approx. $86M, consensus $91.11M
Subscribe for More Information
07:36 EDTDSCIDerma Sciences reports Q2 EPS (34c), consensus (46c)
Reports Q2 revenue $20.9M, consensus $21.47M. “Our AWC business faced headwinds during the second quarter that were specific to the U.S. and were temporary in nature, including reimbursement and competitive pressures. While AWC sales results were below expectations, our franchise continued to grow and I am pleased with how effectively the Derma Sciences team addressed those challenges and how well we are positioned for the future,” said Edward J. Quilty, chairman and CEO.
07:27 EDTIMGNUBS to hold a conference
Subscribe for More Information
05:37 EDTHTWRThoratec downgraded to Neutral from Buy at Goldman
Goldman Sachs downgraded Thoratec to Neutral citing the weaker LVAD market and limited visibility following the company's Q2 results. The firm lowered its price target for shares to $28 from $38. Goldman keeps a Sell rating on peer HeartWare (HTWR) and lowered its price target on the name to $73 from $75.
05:17 EDTCCRNCross Country Healthcare sees Q3 revenue $187M-$192M
Subscribe for More Information
05:16 EDTCCRNCross Country Healthcare reports Q2 EPS (10c), consensus 1c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use